Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectives

This publication has 62 references indexed in Scilit:

• Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
  The Lancet Oncology, 2013
• The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery
  Journal of Urology, 2012
• Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
  Journal of Clinical Oncology, 2011
• Advanced Renal Cell Carcinoma
  Drugs, 2007
• POSTOPERATIVE SURVEILLANCE PROTOCOL FOR PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA BASED ON A VALIDATED PROGNOSTIC NOMOGRAM AND RISK GROUP STRATIFICATION SYSTEM
  Journal of Urology, 2005
• MULTI-INSTITUTIONAL VALIDATION OF A SYMPTOM BASED CLASSIFICATION FOR RENAL CELL CARCINOMA
  Journal of Urology, 2004
• Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study
  Journal of Clinical Oncology, 2004
• Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial
  Journal of Clinical Oncology, 2003
• Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma
  Cancer, 2003
• Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized study
  Cancer, 1996